Dow AgroSciences LLC, a wholly owned subsidiary of Dow Chemical, announced today that the company has identified a new lead molecule for advancement in its alliance with GVK Biosciences (GVK Bio), one of asia’s leading Contract Research Organization.
The newly identified lead compound has been selected for its ability to address a key product goal in support of Dow AgroSciences’ growing agricultural chemicals business.
The discovery research agreement with GVK Bio began in May 2008 with the goal of generating novel molecules for synthesis and testing as fungicides and insecticides. The two companies have benefited from the depth of expertise in medicinal chemistry and chemoinformatics at GVK Bio in combination with Dow AgroSciences’ agricultural chemical capabilities.
"We are very pleased to reach this important milestone with GVK Bio under this collaborative discovery alliance," said Daniel R Kittle, vice president of Research and Development at Dow AgroSciences. "We’re building partnerships world wide to discover creative new solutions in crop protection."